(Q50734762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

FK506, a secondary metabolite produced by Streptomyces, presents a novel antiviral activity against Orthopoxvirus infection in cell culture (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Reis SA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Moussatché N

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

Journal of Applied Microbiology

21 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1373-1380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16696686%20AND%20SRC:MED&resulttype=core&format=json

Induction of a Common Pathway of Apoptosis by Staurosporine

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Comparison of the effect of FK506 and cyclosporin A on virus production in H9 cells chronically and newly infected by HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

An Emergent Poxvirus from Humans and Cattle in Rio de Janeiro State: Cantagalo Virus May Derive from Brazilian Smallpox Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Cyclosporin A inhibits vaccinia virus replication in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Inhibition of vaccinia virus replication by cyclosporin A analogues correlates with their affinity for cellular cyclophilins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Azathioprine inhibits vaccinia virus replication in both BSC-40 and RAG cell lines acting on different stages of virus cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Tacrolimus and transplantation: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Improving DNA vaccine potency by linking Marek's disease virus type 1 VP22 to an antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

An alternative genetic method to test essential vaccinia virus early genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Inhibition of vaccinia virus replication by adenosine in BSC-40 cells: involvement of A(2) receptor-mediated PKA activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Monkeypox: a review of the history and emergence in the Western hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

The mosaic of immunosuppressive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Hsp90 inhibitor geldanamycin and its derivatives as novel cancer chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Exploiting marine actinomycete biosynthetic pathways for drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

The use of two immunosuppressive drugs, cyclosporin A and tacrolimus, to inhibit virus replication and apoptosis in cells infected with feline immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Protein synthesis inhibitory activity in culture filtrates from new strains of Streptomyces isolated from Brazilian tropical soils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Novel bioactive compounds from actinomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

The mechanism of action of cyclosporin A and FK506

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Novobiocin inhibits vaccinia virus replication by blocking virus assembly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Immunosuppressive dose of azathioprine inhibits replication of human cytomegalovirus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Functional association of cyclophilin A with HIV-1 virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Potent and specific inhibitors of protein kinase C of microbial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Antiviral activity of Viracea against acyclovir susceptible and acyclovir resistant strains of herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Calcineurin is essential for DNA synthesis in Swiss 3T3 fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: A degenerate conserved cleavage motif within core proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Exploiting the genetic potential of polyketide producing streptomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Differential utilization of a conserved motif for the proteolytic maturation of vaccinia virus proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X

Smallpox, vaccination and adverse reactions to smallpox vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02855.X